Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'physostigmine' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 673 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Monserrat, JM; Bianchini, A
      Anticholinesterase effect of eserine (physostigmine) in fish and crustacean species

      BRAZILIAN ARCHIVES OF BIOLOGY AND TECHNOLOGY
    2. Giacobini, E
      Do cholinesterase inhibitors have disease-modifying effects in Alzheimer'sdisease?

      CNS DRUGS
    3. Kennedy, LL; Aguwa, CC; Rives, JE; Bernard, DG
      Involvement of cholinergic mechanisms in the central control of respiration in the cane toad, Bufo marinus

      COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR AND INTEGRATIVE PHYSIOLOGY
    4. Yuan, RY; Kao, CR; Sheu, JJ; Chen, CH; Ho, CS
      Delirium following a switch from cimetidine to famotidine

      ANNALS OF PHARMACOTHERAPY
    5. Todorovic, Z; Prostran, M; Vukovic, S
      The influence of L-arginine on heart rate and tissue oxygen extraction in haemorrhaged rabbits

      PHARMACOLOGICAL RESEARCH
    6. Kirrane, RM; Mitropoulou, V; Nunn, M; Silverman, J; Siever, LJ
      Physostigmine and cognition in schizotypal personality disorder

      SCHIZOPHRENIA RESEARCH
    7. Shimizu, C; Yamane, Y; Ishizuka, T; Kijima, H; Takano, K; Takano, A; Kubo, M; Koike, T
      Involvement of the cholinergic pathway in the pathogenesis of pituitary Cushing's syndrome

      ENDOCRINE JOURNAL
    8. Hedner, E; Birkhed, D; Hedner, J; Ekstrom, J; Helander, HF
      Stimulation of minor salivary glands by intraoral treatment with the cholinesterase inhibitor physostigmine in man

      EUROPEAN JOURNAL OF ORAL SCIENCES
    9. Caballero-Bleda, M; Redondo-Aniorte, FJ; Aldeguer-Montiel, A; Popovic, N; Popovic, M; Puelles, L
      NADPH-diaphorase activity in the frontal cortex of NBM-lesioned rats treated with verapamil

      NEUROSCIENCE RESEARCH COMMUNICATIONS
    10. Mentis, MJ; Sunderland, T; Lai, J; Connolly, C; Krasuski, J; Levine, B; Friz, J; Sobti, S; Schapiro, M; Rapoport, SI
      Muscarinic versus nicotinic modulation of a visual task: A PET study usingdrug probes

      NEUROPSYCHOPHARMACOLOGY
    11. Tariot, PN
      Maintaining cognitive function in Alzheimer disease: How effective are current treatments?

      ALZHEIMER DISEASE & ASSOCIATED DISORDERS
    12. Santos-Sanchez, NF; Morales-Rios, MS; Joseph-Nathan, P
      NMR and theoretical conformational studies of the anticholinergic physostigmine

      MAGNETIC RESONANCE IN CHEMISTRY
    13. Sanchez-Fortun, S; Barahona, V
      The use of carbamates, atropine, and 2-pyridine aldoxime methoiodide in the protection of Artemia salina against poisoning by carbophenothion

      ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY
    14. Santos, PF; Almeida, PS; Lobo, AM; Prabhakar, S
      A formal synthesis of (+/-)-eseroline via an azaoxy-cope rearrangement

      HETEROCYCLES
    15. Imbimbo, BP
      Central acetylcholinesterase inhibition in Alzheimer patients

      ANNALS OF NEUROLOGY
    16. Pryse-Phillips, W; Sternberg, S; Rochon, P; Naglie, G; Strong, H; Feightner, J
      The use of medications for cognitive enhancement

      CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
    17. Petrie, EC; Peskind, ER; Dobie, DJ; Veith, RC; Raskind, MA
      Plasma catecholamine and cardiovascular responses to physostigmine in Alzheimer's disease and aging

      PSYCHONEUROENDOCRINOLOGY
    18. Beach, TG; Kuo, YM; Schwab, C; Walker, DG; Roher, AE
      Reduction of cortical amyloid beta levels in guinea pig brain after systemic administration of physostigmine

      NEUROSCIENCE LETTERS
    19. Blomqvist, G; Tavitian, B; Pappata, S; Crouzel, C; Jobert, A; Doignon, I; Di Giamberardino, L
      Quantitative measurement of cerebral acetylcholinesterase using [C-11]physostigmine and positron emission tomography

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    20. Keefer, EW; Norton, SJ; Boyle, NAJ; Talesa, V; Gross, GW
      Acute toxicity screening of novel AChE inhibitors using neuronal networks on microelectrode arrays

      NEUROTOXICOLOGY
    21. Lallement, G; Foquin, A; Dorandeu, F; Baubichon, D; Aubriot, S; Carpentier, P
      Subchronic administration of various pretreatments of nerve agent poisoning. I. Protection of blood and central cholinesterases, innocuousness towards blood-brain barrier permeability

      DRUG AND CHEMICAL TOXICOLOGY
    22. Lallement, G; Foquin, A; Dorandeu, F; Baubichon, D; Carpentier, P
      Subchronic administration of various pretreatments of nerve agent poisoning. II. Compared efficacy against soman toxicity

      DRUG AND CHEMICAL TOXICOLOGY
    23. Qiao, D; Seidler, FJ; Slotkin, TA
      Developmental neurotoxicity of chlorpyrifos modeled in vitro: Comparative effects of metabolites and other cholinesterase inhibitors on DNA synthesisin PC12 and C6 cells

      ENVIRONMENTAL HEALTH PERSPECTIVES
    24. Kant, GJ; Bauman, RA; Feaster, SR; Anderson, SM; Saviolakis, G; Garcia, GE
      The combined effects of pyridostigmine and chronic stress on brain cortical and blood acetylcholinesterase, corticosterone, prolactin and alternationperformance in rats

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    25. Li, Z; Wu, CF; Pei, G; Xu, NJ
      Reversal of morphine-induced memory impairment in mice by withdrawal in Morris water maze - Possible involvement of cholinergic system

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    26. Ebert, U; Grossmann, M; Oertel, R; Gramatte, T; Kirch, W
      Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effects of scopolamine in healthy volunteers

      JOURNAL OF CLINICAL PHARMACOLOGY
    27. Savci, V; Cavun, S; Gurun, MS; Ulus, IH
      Reversal of haemorrhagic shock in rats by tetrahydroaminoacridine

      PHARMACOLOGY
    28. Doody, RS; Stevens, JC; Beck, C; Dubinsky, RM; Kaye, JA; Gwyther, L; Mohs, RC; Thal, LJ; Whitehouse, PJ; DeKosky, ST; Cummings, JL
      Practice parameter: Management of dementia (an evidence-based review) - Report of the Quality Standards Subcommittee of the American Academy of Neurology

      NEUROLOGY
    29. Dehkordi, O; Dennis, GC; Millis, RM; Randolph, MG; Said, B; Trouth, CO
      Synergism between cocaine and atropine at the caudal ventrolateral medullaof cats

      LIFE SCIENCES
    30. Grauer, E; Ben Nathan, D; Lustig, S; Kobiler, D; Kapon, J; Danenberg, HD
      Viral neuroinvasion as a marker for BBB integrity following exposure to cholinesterase inhibitors

      LIFE SCIENCES
    31. Yu, QS; Holloway, HW; Flippen-Anderson, JL; Hoffman, B; Brossi, A; Greig, NH
      Methyl analogues of the experimental Alzheimer drug phenserine: Synthesis and structure/activity relationships for acetyl- and butyrylcholinesterase inhibitory action

      JOURNAL OF MEDICINAL CHEMISTRY
    32. Bolognesi, ML; Andrisano, V; Bartolini, M; Minarini, A; Rosini, M; Tumiatti, V; Melchiorre, C
      Hexahydrochromeno[4,3-b]pyrrole derivatives as acetylcholinesterase inhibitors

      JOURNAL OF MEDICINAL CHEMISTRY
    33. Kim, WG; Song, NK; Yoo, ID
      Quinolactacins A1 and A2, new acetylcholinesterase inhibitors from Penicillium citrinum

      JOURNAL OF ANTIBIOTICS
    34. Nag, S; Tang, F; Yee, BK
      Chronic intracerebroventricular exposure to beta-amyloid(1-40) impairs object recognition but does not affect spontaneous locomotor activity or sensorimotor gating in the rat

      EXPERIMENTAL BRAIN RESEARCH
    35. Carey, GJ; Billard, W; Binch, H; Cohen-Williams, M; Crosby, G; Grzelak, M; Guzik, H; Kozlowski, JA; Lowe, DB; Pond, AJ; Tedesco, RP; Watkins, RW; Coffin, VL
      SCH 57790, a selective muscarinic M-2 receptor antagonist, releases acetylcholine and produces cognitive enhancement in laboratory animals

      EUROPEAN JOURNAL OF PHARMACOLOGY
    36. Ogura, H; Kosasa, T; Kuriya, Y; Yamanishi, Y
      Central and peripheral activity of cholinesterase inhibitors as revealed by yawning and fasciculation in rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    37. Wang, HH; Chou, CJ; Liao, JF; Chen, CF
      Dehydroevodiamine attenuates beta-amyloid peptide-induced amnesia in mice

      EUROPEAN JOURNAL OF PHARMACOLOGY
    38. Kasheverov, I; Rozhkova, A; Zhmak, M; Utkin, Y; Ivanov, V; Tsetlin, VI
      Photoactivatable alpha-constoxins reveal contacts with all subunits as well as antagonist-induced rearrangements in the Torpedo californica acetylcholine receptor

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    39. Grutzendler, J; Morris, JC
      Cholinesterase inhibitors for Alzheimer's disease

      DRUGS
    40. Maelicke, A; Samochocki, M; Jostock, R; Fehrenbacher, A; Ludwig, J; Albuquerque, EX; Zerlin, M
      Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease

      BIOLOGICAL PSYCHIATRY
    41. Wang, GH; Fowler, SC
      Concurrent quantification of tremor and depression of locomotor activity induced in rats by harmaline and physostigmine

      PSYCHOPHARMACOLOGY
    42. Rowsey, PJ; Gordon, CJ
      A peripheral mechanism of fever: differential sensitivity to the antipyretic action of methyl scopolamine

      AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL
    43. Nakagawa, M; Kawahara, M
      A concise synthesis of physostigmine from skatole and activated aziridine via alkylative cyclization

      ORGANIC LETTERS
    44. Kawahara, M; Nishida, A; Nakagawa, M
      An efficient synthesis of optically active physostigmine from tryptophan via alkylative cyclization

      ORGANIC LETTERS
    45. ElAzab, AS; Taniguchi, T; Ogasawara, K
      An expedient route to the calabar bean alkaloids (-)-physovenine and (-)-physostigmine

      ORGANIC LETTERS
    46. Southgate, HJ; Egerton, M; Dauncey, EA
      Lessons to be learned: a case study approach Unseasonal severe poisoning of two adults by deadly nightshade (Atropa belladonna)

      JOURNAL OF THE ROYAL SOCIETY FOR THE PROMOTION OF HEALTH
    47. Imbimbo, BP; Troetel, WM; Martelli, P; Lucchelli, F
      A 6-month, double-blind, placebo-controlled trial of eptastigmine in Alzheimer's disease

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    48. Lilienfeld, S; Parys, W
      Galantamine: Additional benefits to patients with Alzheimer's disease

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    49. Devlin, CL; Schlosser, W; Belz, DT; Kodiak, K; Nash, RF; Zitomer, N
      Pharmacological identification of acetylcholine receptor subtypes in echinoderm smooth muscle (Sclerodactyla briareus)

      COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-PHARMACOLOGY TOXICOLOGY & ENDOCRINOLOGY
    50. Sramek, JJ; Cutler, NR
      Ongoing trials in Alzheimer's disease

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    51. Naranjo, CA; Fourie, J; Herrmann, N; Lanctot, KL; Birt, C; Yau, KK
      Probing peripheral and central cholinergic system responses

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    52. Cummings, JL; Askin-Edgar, S
      Evidence for psychotropic effects of acetylcholinesterase inhibitors

      CNS DRUGS
    53. Philippens, IHCHM; Vanwersch, RAP; Groen, B; Olivier, B; Bruijnzeel, PLB; Melchers, BPC
      Subchronic physostigmine pretreatment in marmosets: Absence of side effects and effectiveness against soman poisoning with negligible postintoxication incapacitation

      TOXICOLOGICAL SCIENCES
    54. Chiodera, P; Volpi, R; Pilla, S; Cataldo, S; Capretti, L; Coiro, V
      Effect of aging on the arginine-vasopressin response to physostigmine and angiotensin II in normal men

      JOURNAL OF INVESTIGATIVE MEDICINE
    55. Pruvost, A; Ragueneau, I; Ferry, A; Jaillon, P; Grognet, JM; Benech, H
      Fully automated determination of eserine N-oxide in human plasma using on-line solid-phase extraction with liquid chromatography coupled with electrospray ionization tandem mass spectrometry

      JOURNAL OF MASS SPECTROMETRY
    56. Kirdemir, P; Ozkocak, I; Demir, T; Gogus, N
      Comparison of postoperative analgesic effects of preemptively used epidural ketamine and neostigmine

      JOURNAL OF CLINICAL ANESTHESIA
    57. Ebert, U; Oertel, R; Kirch, W
      Influence of grapefruit juice on scopolamine pharmacokinetics and pharmacodynamics in healthy male and female subjects

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    58. Himmelheber, AM; Sarter, M; Bruno, JP
      Increases in cortical acetylcholine release during sustained attention performance in rats

      COGNITIVE BRAIN RESEARCH
    59. Mega, MS; Dinov, ID; Lee, L; O'Connor, SM; Masterman, DM; Wilen, B; Mishkin, F; Toga, AW; Cummings, JL
      Orbital and dorsolateral frontal perfusion defect associated with behavioral response to cholinesterase inhibitor therapy in Alzheimer's disease

      JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
    60. Sramek, JJ; Cutler, NR
      RBC cholinesterase inhibition: A useful surrogate marker for cholinesterase inhibitor activity in Alzheimer disease therapy?

      ALZHEIMER DISEASE & ASSOCIATED DISORDERS
    61. Liu, WF
      Effects of cholinesterase inhibitors on a two-component chained schedule performance in rats

      NEUROTOXICOLOGY AND TERATOLOGY
    62. Garza, MB; Osterhoudt, KC; Rutstein, R
      Central anticholinergic syndrome from orphenadrine in a 3 year old

      PEDIATRIC EMERGENCY CARE
    63. Ogura, H; Kosasa, T; Kuriya, Y; Yamanishi, Y
      Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrylcholinesterase in vitro

      METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    64. Karan, RS; Ravishankar, P; Pandhi, P
      Effect of muscarinic receptor agonists on animal models of psychosis

      METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    65. Ogura, H; Kosasa, T; Kuriya, Y; Yamanishi, Y
      Donepezil, a centrally acting acetylcholinesterase inhibitor, alleviates learning deficits in hypocholinergic models in rats

      METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    66. Nitsch, RM; Deng, MH; Tennis, M; Schoenfeld, D; Growdon, JH
      The selective muscarinic M1 agonist AF102B decreases levels of total A beta in cerebrospinal fluid of patients with Alzheimer's disease

      ANNALS OF NEUROLOGY
    67. Giacobini, E
      Cholinesterase inhibitors stabilize Alzheimer disease

      NEUROCHEMICAL RESEARCH
    68. Chen, JL; Yeh, MK; Chiang, CH
      Anaerobic stability of aqueous physostigmine solution

      DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
    69. Furey, ML; Pietrini, P; Alexander, GE; Schapiro, MB; Horwitz, B
      Cholinergic enhancement improves performance on working memory by modulating the functional activity in distinct brain regions: A positron emission tomography regional cerebral blood flow study in healthy humans

      BRAIN RESEARCH BULLETIN
    70. Ostermann, ME; Young, B; Sibbald, WJ; Nicolle, MW
      Coma mimicking brain death following baclofen overdose

      INTENSIVE CARE MEDICINE
    71. Fujii, T; Harada, H; Koyama, T; Nakajima, Y; Kawashima, K
      Effects of physostigmine and calcium on acetylcholine efflux from the hippocampus of freely moving rats as determined by in vivo microdialysis and a radioimmunoassay

      NEUROSCIENCE LETTERS
    72. Sienkiewicz-Jarosz, H; Czlonkowska, AI; Siemiatkowski, M; Maciejak, P; Szyndler, J; Plaznik, A
      The effects of physostigmine and cholinergic receptor ligands on novelty-induced neophobia

      JOURNAL OF NEURAL TRANSMISSION
    73. Bueno, OFA; Oliveira, MGM; Lobo, LL; Morais, PR; Melo, FHM; Tufik, S
      Cholinergic modulation of inhibitory avoidance impairment induced by paradoxical sleep deprivation

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    74. Rowland, CA; Chilcott, RP
      The electrostability and electrically assisted delivery of an organophosphate pretreatment (physostigmine) across human skin in vitro

      JOURNAL OF CONTROLLED RELEASE
    75. Maelicke, A; Schrattenholz, A; Samochocki, M; Radina, M; Albuquerque, EX
      Allosterically potentiating ligands of nicotinic receptors as a treatment strategy for Alzheimer's disease

      BEHAVIOURAL BRAIN RESEARCH
    76. Sarkar, S; Thomas, B; Muralikrishnan, D; Mohanakumar, KP
      Effects of serotoninergic drugs on tremor induced by physostigmine in rats

      BEHAVIOURAL BRAIN RESEARCH
    77. Weiner, MF; Martin-Cook, K; Foster, BM; Saine, K; Fontaine, CS; Svetlik, DA
      Effects of donepezil on emotional/behavioral symptoms in Alzheimer's disease patients

      JOURNAL OF CLINICAL PSYCHIATRY
    78. Hurh, E; Lee, EJ; Kim, YG; Kim, SY; Kim, SH; Kim, YC; Lee, MG
      Effects of physostigmine on the pharmacokinetics of intravenous parathion in rats

      BIOPHARMACEUTICS & DRUG DISPOSITION
    79. Furey, ML; Pietrini, P; Alexander, GE; Mentis, MJ; Szczepanik, J; Shetty, U; Greig, NH; Holloway, HW; Schapiro, MB; Freo, U
      Time course of pharmacodynamic and pharmacokinetic effects of physostigmine assessed by functional brain imaging in humans

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    80. Philippens, LHCHM; Melchers, BPC; Olivier, B; Bruijnzeel, PLB
      Scopolamine augments the efficacy of physostigmine against soman poisoningin guinea pigs

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    81. Futagawa, H; Kakinuma, Y; Takahashi, H
      The role of cholinergic and noncholinergic mechanisms in the cardiorespiratory failure produced by N-methylcarbamate cholinesterase inhibitors in rabbits

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    82. Futagawa, H; Takahashi, H
      Pharmacological analysis of noncholinergic action of 2-sec-butylphenyl N-methylcarbamate insecticide on the isolated rabbit aorta

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    83. Sinton, CM; Fitch, TE; Petty, F; Haley, RW
      Stressful manipulations that elevate corticosterone reduce blood-brain barrier permeability to pyridostigmine in the rat

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    84. Grauer, E; Alkalai, D; Kapon, J; Cohen, G; Raveh, L
      Stress does not enable pyridostigmine to inhibit brain cholinesterase after parenteral administration

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    85. Zhu, XX; Greig, NH; Holloway, HW; Whittaker, NF; Brossi, A; Yu, QS
      A practical conversion of natural physostigmine into the potent butyrylcholinesterase inhibitor N-1,N-8-bisnorcymserine

      TETRAHEDRON LETTERS
    86. Zhao, Y; Ku, YL; Hao, XJ; Lee, SS
      Preparation of analogues of Territrem B, a potent AChE inhibitor

      TETRAHEDRON
    87. Ishibashi, H; Kobayashi, T; Machida, N; Tamura, O
      A new efficient route to (+/-)-physostigmine and(+/-)-physovenine by meansof 5-exo selective aryl radical cyclization of o-bromo-N-acryloylanilides

      TETRAHEDRON
    88. Meloun, M; Cernohorsky, P
      Thermodynamic dissociation constants of isocaine, physostigmine and pilocarpine by regression analysis of potentiometric data

      TALANTA
    89. Wang, RH; Bejar, C; Weinstock, M
      Gender differences in the effect of rivastigmine on brain cholinesterase activity and cognitive function in rats

      NEUROPHARMACOLOGY
    90. Thal, LJ; Forrest, M; Loft, H; Mengel, H
      Lu 25-109, a muscarinic agonist, fails to improve cognition in Alzheimer'sdisease

      NEUROLOGY
    91. Winckelmann, U; Lubke, G; Brockstedt, M; Schanz, I; Dechent, J; Weber, J; Albani, M
      Anticholinergic syndrome after ingestion of Angel's Trumpet tea

      MONATSSCHRIFT KINDERHEILKUNDE
    92. Jeyarasasingam, G; Yeluashvili, M; Quik, M
      Nitric oxide is involved in acetylcholinesterase inhibitor-induced myopathy in rats

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    93. Brandsgaard, R; Barrett, JE; Rosenzweig-Lipson, S
      Pharmacological characterization of the discriminative stimulus effects ofthe potassium channel blocker 4-aminopyridine in rats

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    94. Jones, CK; Shannon, HE
      Muscarinic cholinergic modulation of prepulse inhibition of the acoustic startle reflex

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    95. Ishizawa, Y; Ma, HC; Dohi, S; Shimonaka, H
      Effects of cholinomimetic injection into the brain stem reticular formation on halothane anesthesia and antinociception in rats

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    96. Beach, TG; Kuo, YM; Spiegel, K; Emmerling, MR; Sue, LI; Kokjohn, K; Roher, AE
      The cholinergic deficit coincides with A beta deposition at the earliest histopathologic stages of Alzheimer disease

      JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
    97. Zwart, R; van Kleef, RGDM; Gotti, C; Smulders, CJGM; Vijverberg, HPM
      Competitive potentiation of acetylcholine effects on neuronal nicotinic receptors by acetylcholinesterase-inhibiting drugs

      JOURNAL OF NEUROCHEMISTRY
    98. Maelicke, A; Albuquerque, EX
      Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's disease

      EUROPEAN JOURNAL OF PHARMACOLOGY
    99. Kosasa, T; Kuriya, Y; Matsui, K; Yamanishi, Y
      Inhibitory effect of orally administered donepezil hydrochloride (E2020), a novel treatment for Alzheimer's disease, on cholinesterase activity in rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    100. Ghelardini, C; Galeotti, N; Bartolini, A
      Loss of muscarinic antinociception by antisense inhibition of M-1 receptors

      BRITISH JOURNAL OF PHARMACOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/10/20 alle ore 22:07:51